45,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
23 °P sammeln
  • Broschiertes Buch

Highlighting the use of colloidal dispersions as eyedrop formulations containing single or dual drugs has garnered significant interest. This book covers the development of formulas, preclinical safety evaluation, and animal studies for single drug-loaded emulsion eyedrops. It explains how to convert liquid-retentive eyedrops into solid-dry powder for reconstitution, prolonging colloidal stability. Applying a polymer coat to dispersed oil droplets forms nanocapsules, extending drug release in nanocapsule-based eyedrops. The book elucidates two-compartment formation in nanocapsules and emulsion…mehr

Produktbeschreibung
Highlighting the use of colloidal dispersions as eyedrop formulations containing single or dual drugs has garnered significant interest. This book covers the development of formulas, preclinical safety evaluation, and animal studies for single drug-loaded emulsion eyedrops. It explains how to convert liquid-retentive eyedrops into solid-dry powder for reconstitution, prolonging colloidal stability. Applying a polymer coat to dispersed oil droplets forms nanocapsules, extending drug release in nanocapsule-based eyedrops. The book elucidates two-compartment formation in nanocapsules and emulsion eyedrops, accommodating different drugs without interactions. Dual drug-loaded colloidal dispersions manage moderate to severe dry eye syndrome, achieving combination therapy and inflammation reduction.
Autorenporträt
Tamilvanan Shunmugaperumal, Ph.D: Studied Pharmacy at Annamalai University, Madras Medical College and Jadavpur University, India. Post-doctoral fellow at Hebrew University of Jerusalem, Israel and University of Antwerp, Belgium. Currently he works in International Medical University, Kuala Lumpur, Malaysia.